Randomly amplified polymorphic DNA (RAPD) polymerase chain reaction assay for identification of Schistosoma mansoni strains sensitive or tolerant to anti-schistosomal drugs
Mh. Tsai et al., Randomly amplified polymorphic DNA (RAPD) polymerase chain reaction assay for identification of Schistosoma mansoni strains sensitive or tolerant to anti-schistosomal drugs, J PARASITOL, 86(1), 2000, pp. 146-149
The genetic differences between Schistosoma mansoni strains from different
geographic areas that were reportedly resistant or sensitive to anti-schist
osomal drugs were studied with randomly amplified polymorphic DNA (RAPD) an
d simple sequence repeat (SSR) polymerase chain reaction (PCR) assays. Of t
he 20 RAPD primers we chose, 19 showed the capacity to produce a medium to
high level of amplification and 6 revealed difference PCR bands between dru
g-resistant and drug-sensitive strains. One particular primer, 5'-CAGCGACAA
G-3', showed 2 major difference bands between praziquantel (PZQ)-resistant
and PZQ-sensitive strains from the endemic area of Egypt. These results dem
onstrate that defined sequence primers could be applied as a useful tool fo
r differentiating drug-resistant and -sensitive schistosome parasites in th
e field.